Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C33H41ClN2O9 |
Molecular Weight | 645.14 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 2 / 2 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
COC1=CC=CC([C@H]2O[C@H](CC(=O)N3CCC(CC(O)=O)CC3)C(=O)N(CC(C)(C)COC(C)=O)C4=C2C=C(Cl)C=C4)=C1OC
InChI
InChIKey=CMLUGNQVANVZHY-POURPWNDSA-N
InChI=1S/C33H41ClN2O9/c1-20(37)44-19-33(2,3)18-36-25-10-9-22(34)16-24(25)30(23-7-6-8-26(42-4)31(23)43-5)45-27(32(36)41)17-28(38)35-13-11-21(12-14-35)15-29(39)40/h6-10,16,21,27,30H,11-15,17-19H2,1-5H3,(H,39,40)/t27-,30-/m1/s1
Molecular Formula | C33H41ClN2O9 |
Molecular Weight | 645.14 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 2 / 2 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Originator
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Synthesis of novel 4,1-benzoxazepine derivatives as squalene synthase inhibitors and their inhibition of cholesterol synthesis. | 2002 Sep 26 |
|
Lipid-lowering properties of TAK-475, a squalene synthase inhibitor, in vivo and in vitro. | 2003 Jul |
|
Squalene synthase inhibition: a novel target for the management of dyslipidemia. | 2007 Jan |
|
Lapaquistat acetate: development of a squalene synthase inhibitor for the treatment of hypercholesterolemia. | 2011 May 10 |
Patents
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 16:10:13 GMT 2023
by
admin
on
Fri Dec 15 16:10:13 GMT 2023
|
Record UNII |
IUH3AY74O3
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C29703
Created by
admin on Fri Dec 15 16:10:13 GMT 2023 , Edited by admin on Fri Dec 15 16:10:13 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
IUH3AY74O3
Created by
admin on Fri Dec 15 16:10:13 GMT 2023 , Edited by admin on Fri Dec 15 16:10:13 GMT 2023
|
PRIMARY | |||
|
9874248
Created by
admin on Fri Dec 15 16:10:13 GMT 2023 , Edited by admin on Fri Dec 15 16:10:13 GMT 2023
|
PRIMARY | |||
|
189060-13-7
Created by
admin on Fri Dec 15 16:10:13 GMT 2023 , Edited by admin on Fri Dec 15 16:10:13 GMT 2023
|
PRIMARY | |||
|
SS-96
Created by
admin on Fri Dec 15 16:10:13 GMT 2023 , Edited by admin on Fri Dec 15 16:10:13 GMT 2023
|
PRIMARY | |||
|
SUB32261
Created by
admin on Fri Dec 15 16:10:13 GMT 2023 , Edited by admin on Fri Dec 15 16:10:13 GMT 2023
|
PRIMARY | |||
|
CHEMBL435224
Created by
admin on Fri Dec 15 16:10:13 GMT 2023 , Edited by admin on Fri Dec 15 16:10:13 GMT 2023
|
PRIMARY | |||
|
DTXSID50432130
Created by
admin on Fri Dec 15 16:10:13 GMT 2023 , Edited by admin on Fri Dec 15 16:10:13 GMT 2023
|
PRIMARY | |||
|
DB05317
Created by
admin on Fri Dec 15 16:10:13 GMT 2023 , Edited by admin on Fri Dec 15 16:10:13 GMT 2023
|
PRIMARY | |||
|
C81535
Created by
admin on Fri Dec 15 16:10:13 GMT 2023 , Edited by admin on Fri Dec 15 16:10:13 GMT 2023
|
PRIMARY | |||
|
100000124421
Created by
admin on Fri Dec 15 16:10:13 GMT 2023 , Edited by admin on Fri Dec 15 16:10:13 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |